Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02537561
Title Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine

lung non-small cell carcinoma

Advanced Solid Tumor



Cisplatin + Gemcitabine

Age Groups: adult
Covered Countries

No variant requirements are available.